Maximising the Value of Imaging in Oncology Drug Development

Event contact first name
Event contact last name
Event contact telephone number
44 207 827 6734
Receive a £300 discount if you book online with the following code: SMI9C9U
Imaging allows us to answer questions that we did not know the answer to before. For example, it can help determine the composition of the tumour, clinical evaluation of patients and evaluation of new treatments. Imaging within the arena of personalised healthcare is an area of increasing significance and will revolutionise the field of oncology. Attendees will be given practical tips and guidance on cost-effective imaging management, regulatory insights will be provided and alternatives to costly independent reviews will be discussed. The use of imaging in clinical trials (Phases 2 and 3) will be considered and debated in addition to the use of novel biomarkers. This 2 day event will be an excellent opportunity for professionals working in imaging to talk to renowned speakers. There will be a diverse selection of speakers, representing all areas of the field. From US to UK, attendees will gain a broad analysis of ideas, challenges and solutions. Key Speakers Include: • Dr Azeem Saleem, Head of Oncology Applications, Imanova Centre for Imaging Sciences • Lori Dodd, PhD, Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, US National Institutes of Health • Dr Marijn Vlaming, Research Scientist, TNO • Prash Krishna, Global Clinical Leader - Oncology, Novartis • Pallavi Chaturvedi, Imaging Project Manager, GSK Vesalius Imaging • Francois Lassailly, Head of in Vivo Imaging, Cancer Research UK • Dr Malcom Barratt-Johnson, Managing Director, PharmaMedic Consultancy • Werner Scheuer, Research Leader, Preclinical Imaging, Pharma Research and Early Development, Discovery Oncology, Roche Diagnostics GmbH • Dr Yan Liu, Head of Department – Translational Research, Radiotherapy and Imaging, EORTC Why Attend In 2014: • Explore new opportunities for cost-effective imaging management • Discover new alternatives to expensive independent reviews – hear from globally recognised experts • Discuss & debate case studies, challenges and opportunities in imaging guidelines featuring Novartis and GSK • Gain an in-depth insight into the challenges of imaging in Europe • Evaluate & strategize the power of imaging Register online with the following code and receive a £300 discount: SMI9C9U For full programme, brochure and more information please visit our website: Network with: Janssen, Roche Diagnostics, Novartis, Hoffmann-La Roche, GlaxoSmithKline, Merck KGaA, BioClinica, Lyscaut, Cancer Research UK, TNO, ICON Clinical Research, Asia HealthPartners, Aviesan, Banook Group, Cardiff University, EORTC, PAREXEL European Society of Oncologic Imaging, Imanova, National Institute of Allergy and Infectious Diseases (NIH), UZ Leuven, Edinburgh University, Virtual Scopics and many more Pharmaceutical companies can book on for only £999 – Please contact Jonathan Collins at | +44 207 827 6734 for this rate
Attendee information
Chief Executives, Executive Directors, Vice Presidents, Directors, Heads, Managers, Senior Scientists, Group Leaders of Imaging Medical Imaging Cancer Drug Development Oncology Preclinical oncology Clinical Oncology Research and Development Clinical Technology Specialised Therapeutics Clinical Development Oncology Consultancy Legislation and Policy Advice
Exhibitor information

Previous attendees from our 2013 conference include: BioClinica; Biospace Lab; Cancer Research UK; EANM Research; Eisai; Eisai Europe Ltd; Foundation for Liver Research; GLAXOSMITHKLINE; GSK; Hoffmann-La Roche; Imperial College; Intrasense; Ipsen Ltd; MEDIAN Technologies; Medipan Diagnostica; Merck; MRC; Newcastle University; NTEC; Roche Diagnostics; Roche Products; Royal Marsden N H S Trust (The); Sussex University; The Beatson Institute For Cancer Research; UCL Cancer Institute; University College; University of Cambridge and Cancer Research UK; Virtual Scopics L L C; Vision Healthcare Consultancy Ltd; VU University Medical Centre;

Partner Voices

Sporting events are no longer the most preferred target for terrorists, according to the Department of Homeland Security. Outdoor events, conferences, festivals, and other events featuring public figures are all vulnerable. And with over a thousand different-level attacks since 2015, it’s no surprise that safety and security are among the top concerns for event professionals.